On certain complex patient safety issues, PBSA will draft more in depth statements to fully explain patients' concerns.
- PBSA Position on Interchangeability of Biosimilars
- PBSA Position on BsUFA Announcement and Guidance Delays
- PBSA Switching Position Statement
- PBSA Position on the Labeling of Biosimilars
Individual member organizations have position statements on biosimilar issues that are especially important to patients. For more specific information, click below.